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Phialophora verrucosa is a dematiaceous fungus able to cause chromoblastomycosis,
phaeohyphomycosis and mycetoma. All these fungal diseases are extremely difficult
to treat and often refractory to the current therapeutic approaches. Therefore,
there is an urgent necessity to develop new antifungal agents to combat these
mycoses. In this context, the aim of the present work was to investigate the
effect of 1,10-phenanthroline-5,6-dione (phendione) and its metal-based derivatives
[Ag(phendione)2]ClO =4 ([Ag(phendione)2]
+) and [Cu(phendione)3](ClO4)2.4H2O =
([Cu(phendione)3]
2+) on crucial physiological events of P. verrucosa conidial cells.
Using the CLSI protocol, we have shown that phendione, [Ag(phendione)2]
+ and
[Cu(phendione)3]
2+ were able to inhibit fungal proliferation, presenting MIC/IC50 values of
12.0/7.0, 4.0/2.4, and 5.0/1.8µM, respectively. [Cu(phendione)3]
2+ had fungicidal action
and when combined with amphotericin B, both at sub-MIC (½ × MIC) concentrations,
significantly reduced (∼40%) the fungal growth. Cell morphology changes inflicted by
phendione and its metal-based derivatives was corroborated by scanning electron
microscopy, which revealed irreversible ultrastructural changes like surface invaginations,
cell disruption and shrinkages. Furthermore, [Cu(phendione)3]
2+ and [Ag(phendione)2]
+
were able to inhibit metallopeptidase activity secreted by P. verrucosa conidia by
approximately 85 and 40%, respectively. Ergosterol content was reduced (∼50%) after
the treatment of P. verrucosa conidial cells with both phendione and [Ag(phendione)2]
+.
To different degrees, all of the test compounds were able to disturb the P. verrucosa
conidia-into-mycelia transformation. Phendione and its Ag+ and Cu2+ complexes
may represent a promising new group of antimicrobial agents effective at inhibiting
P. verrucosa growth and morphogenesis.
Keywords: Phialophora verrucosa, 1,10-phenanthroline-5,6-dione, metal-based drugs, antifungal activity,
chromoblastomycosis
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INTRODUCTION
Phialophora verrucosa is a melanized pathogenic fungus
associated with a wide range of neglected diseases including
phaeohyphomycosis, mycetoma, keratitis, endophthalmitis,
osteomyelitis and endocarditis (Turiansky et al., 1995; Revankar
and Sutton, 2010; Sun et al., 2010; Tong et al., 2013). However,
this fungus is especially known to cause chromoblastomycosis
(CBM), which is a chronic, progressive disease affecting
the cutaneous and subcutaneous tissues (Torres-Guerrero
et al., 2012; Krzys´ciak et al., 2014). Clinically, CBM is
characterized by pseudoepitheliomatous hyperplasia with
epidermal microabscesses and dermal granuloma. Chronic CBM
lesions may undergo neoplastic transformation leading to skin
cancer (Queiroz-Telles and Santos, 2012). This disease is most
prevalent among individuals with outdoor occupations, such as
farmers, gardeners and agricultural laborers. This risk group is
usually exposed to soil, wood and rotting vegetation, which are
the ubiquitous natural habitats of the fungal etiologic agents of
CBM (Torres-Guerrero et al., 2012; Vicente et al., 2014). CBM
usually occurs through trauma or skin penetration of fungal
propagules in individuals lacking adequate protective footwear
and clothing (Torres-Guerrero et al., 2012). This widespread
mycosis is mostly common in tropical and subtropical regions
of Africa, Asia, Australia and Latin America, with particular
foci in Brazil, Madagascar, Mexico, Dominican Republic,
Venezuela and India (Ameen, 2010; Krzys´ciak et al., 2014). Due
to the chronic nature and the well-known multidrug-resistance
profile, it is very difficult to treat patients with CBM using
currently available therapies (Queiroz-Telles and Santos, 2012).
Prolonged treatment and disease relapsed are huge concerns,
and antifungal therapies especially for Phialophora infections
have generally been disappointing (Gao et al., 2013). For these
reasons, new antifungal agents should be studied in order to
find out alternative therapeutic ways to treat CBM and other
infections caused by P. verrucosa.
In the last years, metal-based drugs have been a subject of
great interest due to their therapeutic values and pharmacological
applications (Zhang and Lippard, 2003; Warra, 2011; Viganor
et al., 2015). 1,10-Phenanthroline-5,6-dione (phendione) is a
phenanthrene-based ligand and a derivative of the classical
chelating agent 1,10-phenanthroline (Calderazzo et al., 2002;
McCann et al., 2012a). Phendione has a structure similar to
1,10-phenanthroline with the addition of two carbonyl groups
attached at positions 5 and 6. The bifunctional character
of phendione made it an extremely versatile ligand, with
special reactivity arising from its quinonoid and diiminic sites
(Calderazzo et al., 2002; Calucci et al., 2006). The quinonoid
functionality of phendione confers redox capability, whilst
the juxtaposition is two N atoms make it ideally suited
to chelating transition metal ions (Calderazzo et al., 2002;
Calucci et al., 2006; McCann et al., 2012b). Phendione, both
in its metal-free state and when coordinated to metal ions,
is considered to have many interesting biological properties,
such as anticancer and antimicrobial actions (McCann et al.,
2004, 2012a; Deegan et al., 2006; Roy et al., 2008; Pivetta et al.,
2014; Viganor et al., 2016). In recent years, researchers
have synthesized several phendione-based compounds,
including [Ag(phendione)2]ClO4 = [Ag(phendione)2]+
and [Cu(phendione)3](ClO4)2.4H2O = [Cu(phendione)3]2+
(McCann et al., 2004), in an attempt to generate new complexes
with improved antimicrobial activity and reduced toxicity
to different cell lineages, Galleria mellonella larvae and mice
(McCann et al., 2012a). [Cu(phendione)3]2+ was found to
be active against the multi-resistant, filamentous fungus,
Scedosporium apiospermum, while [Ag(phendione)2]+ exhibited
better activity against the yeast, Candida albicans (McCann
et al., 2012a). Moreover, [Ag(phendione)2]+ caused extensive
and non-specific DNA cleavage, disrupted cell division and
caused severe morphological alterations in C. albicans yeast
cells (Eshwika et al., 2004; McCann et al., 2012a). Metal-free
phendione exerts its antimicrobial effect in several ways, such
as disturbing the microorganism’s crucial metal metabolism
as well as interfering in its metal ion acquisition and its
bioavailability for essential reactions (e.g., inhibiting the activity
of metalloproteins), affecting the microbial cell homeostasis
and culminating in the blockage of primordial biological events
(e.g., nutrition, proliferation, differentiation, adhesion, invasion,
dissemination and infection) (Santos et al., 2012). Protease
inhibition is also a prime cellular target of this class of ligand
and its associated metal complexes (Kellett et al., 2013). In this
context, the aim of the present work was to investigate the effect
of phendione and its Ag+ and Cu2+ complexes on P. verrucosa




All reagents used in electrophoresis and buffers components
were purchased from Bio-Rad (Hercules, CA, USA) and
Merck (Darmstaldt, Germany). Human serum albumin (HSA),
1,10-phenanthroline, resazurin, AgClO4, Cu(ClO4)2·6H2O,
dimethyl sulfoxide (DMSO), 3-(N-morpholino) propanesulfonic
acid (MOPS), itraconazole (ITC), amphotericin B (AMB)
ketoconazole (KTC), ergosterol, lanosterol, silica gel 60
plates, Czapek-Dox and Sabouraud-dextrose agar (SDA)
components were obtained from Sigma-Aldrich Chemical Co
(St Louis, MO, USA). Roswell Park Memorial Institute (RPMI)
1640 medium was purchased from Invitrogen (Camarillo,
CA, USA). 1,10-Phenanthroline-5,6-dione (phendione),
[Cu(phendione)3](ClO4)2·4H2O ([Cu(phendione)3]2+) and
[Ag(phendione)2]ClO4 ([Ag(phendione)2]+) were prepared in
accordance with published procedures (McCann et al., 2004).
Microorganism and Growth Condition
Phialophora verrucosa (FMC.2214 strain) isolated from a
human patient with CBM was grown on SDA medium.
Fungal cells were cultivated for 7 days under constant
agitation (130 rpm) at 26◦C in 100 ml of Czapek-Dox,
a chemically defined medium containing: 3 g sucrose; 0.3 g
NaNO3; 0.05 g MgSO4.7H2O; 0.05 g KCl; 0.1 g KH2PO4;
0.001 g FeSO4.7H2O, pH 5.5. Conidia were obtained after
gauze filtration followed by centrifugation (4.000 × g/10
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min). Then, conidia were washed three times in 0.85%
NaCl and cell density estimated by counting in a Neubauer
chamber (Granato et al., 2015). All the experiments with
P. verrucosa were conducted under Biosafety Level 2 (BSL-2)
conditions.
Effects of Test Compounds on P. verrucosa
Growth
Antifungal susceptibility testing was performed using the
M38-A2 document for filamentous fungi as described by
Clinical and Laboratory Standards Institute (CLSI, 2008) with
some modifications (Granato et al., 2015). Briefly, the broth
microdilution method was carried out using 96-well microtiter
assay plates containing RPMI 1640 medium at pH 7.0 buffered
with 0.16 M MOPS. All the test compounds were dissolved in
DMSO and the maximum concentration of organic solvent was
2.0%. Serial dilution was made following CLSI guidelines in order
to obtain final concentrations ranging from 0.01 to 20 mg/L of
phendione and its derivatives, as well as the simple salts, AgClO4
and Cu(ClO4)2·6H2O. The minimum inhibitory concentration
(MIC) for each test compound was determined after 5 days
of incubation by visual inspection and resazurin staining assay
(Liu et al., 2007). The lowest concentration capable in inhibiting
100% of fungal growth was recorded as the MIC. ITC (0.01 to
100 mg/L) was used as reference antifungal drug. In addition,
the minimum fungicidal concentration (MFC) was established
before microtiter plate (MIC assay) spectrophotometric reading,
in which the contents of the plate wells were homogenized
and an aliquot from each well was transferred onto SDA drug-
free plates. The plates were incubated at 30◦C for 10 days
and MFC was determined as the lowest concentration without
visual fungal growth. A fungicidal effect was defined as the
MFC value equal or up to four times the MIC value, as
proposed by Pfaller et al. (2004). The IC50 value, defined as
the drug concentration (µM) able to cause a 50% reduction
in fungal viability, was also calculated by using logarithmic
regression after MIC determination, as detailed by Granato et al.
(2015).
Effects of Test Compounds on P. verrucosa
Ultrastructure
The fungal ultrastructure was evaluated using scanning
electron microscopy (SEM). Briefly, conidia (5 × 107 cells)
were incubated for 20 h at 26◦C in the absence (control)
or in the presence of phendione, [Ag(phendione)2]+ or
[Cu(phendione)3]2+ at concentrations corresponding to MIC
and 2 × MIC. Subsequently, the conidia were washed and
fixed with 4% paraformaldehyde and 2.5% glutaraldehyde in
0.15 M sodium cacodylate buffer (pH 7.2) at 26◦C for 2 h.
Cells were washed and then post-fixed for 1 h at 26◦C with
1% OsO4 in the same buffer. Next, samples were dehydrated
using a graded series of ethanol (50–100%), and dried by
the critical point method. Finally, the samples were mounted
on stubs, coated with gold and observed using a Jeol JSM
6490LV scanning electron microscope (Abi-chacra et al.,
2013).
Effects of Combinations of
[Cu(phendione)3]
2+ with Classical
Antifungals on P. verrucosa Growth
All the test compounds were dissolved in DMSO. P. verrucosa
conidia (1 × 103/ml) were exposed to individual clinically used
antifungal drugs [AMB (3.12 mg/L), KTC (1.56 mg/L) and
ITC (0.78 mg/L) at concentration values corresponding to ½
× MIC of each drug] and also to [Cu(phendione)3]2+ (½ ×
MIC). In addition, combinations of separate samples of AMB,
KTC and ITC with [Cu(phendione)3]2+ at these concentrations
were also screened for 1 h at 26◦C. After exposure, 0.1ml of
each system was plated onto solid Czapek-Dox medium without
drugs and incubated for 5 days at 26◦C. Fungal growth was
estimated by counting colony-forming units (CFU) (Palmeira
et al., 2008) and the results were compared to the untreated
control.
Effects of Test Compounds on the
Metallopeptidase Activity of P. verrucosa
P. verrucosa conidial cells (5 × 109) were resuspended in 0.2 ml
of sterile phosphate-buffered saline (PBS, pH 7.2) supplemented
with 2% glucose and incubated with constant agitation (130
rpm). After 2 h, conidia were removed by centrifugation (4000
× g/10min) and the cell-free PBS-glucose supernatant was
subjected to a peptidase activity assay as described by Granato
et al. (2015). Briefly, 15 µl of cell-free PBS-glucose supernatant
(10 µg of protein) and 1.5 µl HSA (1mg/ml) were incubated
for 20 h at 37◦C in the absence (control) or in the presence of
the classical metallopeptidase inhibitor, 1,10-phenanthroline
(10 mM), and 8 × MIC of the test compounds, phendione,
[Ag(phendione)2]+ and [Cu(phendione)3]2+. The reaction
mixtures were then added to 15 µl sample buffer (125 mM
Tris, pH 6.8, 4% SDS, 20% glycerol, 0.002% bromophenol
blue and 10% β-mercaptoethanol), boiled at 100◦C for 5min,
and subjected to sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE). Electrophoresis was carried out
at 4◦C, 120 V for 1.5 h. The degradation protein profiles were
detected by silver staining (Granato et al., 2015). Densitometric
quantification was performed using the free ImageJ
software.
Effects of Test Compounds on Sterol
Content
Conidia (1 × 107/ml) were incubated in Czapek-Dox medium
in the absence (control) or in the presence of sub-inhibitory
concentrations (½ × MIC and ¼ × MIC) of phendione,
[Ag(phendione)2]+ or [Cu(phendione)3]2+. After 48 h, conidia
were washed in PBS and total lipids were extracted with
chloroform:methanol (2:1, 1:1 and 1:2). The combined extracts
were mixed, dried and Folch partition was then performed (Folch
et al., 1957). The lower phase containing the neutral lipids was
recovered, evaporated and subjected to high performance thin
layer chromatography (HPTLC). Chromatography was carried
out on silica gel 60 plates, which were developed with a solvent
system containing hexane:ether:acetic acid (60:30:1.5). The spots
(violet-red color) were visualized after spraying the plate with
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a reagent (comprising 50mg iron chloride, 5ml sulfuric acid,
5ml acetic acid and 90ml distilled water) and subsequent heating
(Larsen et al., 2004). The sterol standards, ergosterol (4 µg) and
lanosterol (1 µg) were used. Sterol quantitative determination
was performed using ImageJ software.
Effects of Test Compounds on P. verrucosa
Morphogenesis
Conidia (1 × 106/ml) were incubated at 26◦C in the absence
(control) or in the presence of sub-inhibitory concentrations
(½ × MIC and ¼ × MIC) of phendione, [Ag(phendione)2]+
or [Cu(phendione)3]2+ in RPMI medium, pH 7.0 (without
agitation), in order to induce the filamentation in P. verrucosa.
The fungal cells were then observed using a Carl Zeiss
MicroImaging GmbH optical microscope and images obtained
every 24 h (Granato et al., 2015). Conidial viability after the
treatment with the test compounds was performed using the
resazurin assay (Liu et al., 2007).
Statistical Analysis
All experiments were performed in triplicate in three
independent experimental sets. The graphics and data were
constructed and analyzed statistically by means of Student’s t-test
using GraphPad Prism 5.01 software. P values of 0.05 or less were
assumed as significant.
RESULTS AND DISCUSSION
Anti-P. verrucosa Action of Phendione and
Its Metal Complexes
The in vitro antifungal activities of phendione and its Ag+
and Cu2+ complexes were evaluated against P. verrucosa.
All of the test compounds inhibited conidial cell growth
with the following activity order based on the IC50 values
(µM): [Cu(phendione)3]2+ > [Ag(phendione)2]+ > phendione
(Figure 1). Only [Cu(phendione)3]2+ showed a fungicidal effect.
These data corroborate previously published results, which
revealed that phendione-based metal complexes had higher
antimicrobial activity thanmetal-free phendione toward different
classes of microorganisms (McCann et al., 2012a; Viganor et al.,
2016).
In order to confirm that the cytotoxic effect observed was
due to the complexes, rather than the free Ag+ and Cu2+
ions, the antifungal activities of the simple perchlorate salts,
Cu(ClO4)2·6H2O and AgClO4, were also assessed (Figure 1).
While AgClO4 showed moderate anti-P. verrucosa activity (MIC
24.0 µM), Cu(ClO4)2·6H2O did not affect fungal growth,
even at the maximum test concentration (MIC > 54.0 µM).
The results showed that Ag+ coordinated to phendione
([Ag(phendione)2]+) was about 6 times more effective (MIC
4.0 µM) than simple AgClO4 (MIC 24.0 µM). Although,
Cu(ClO4)2·6H2O was essentially inactive (MFC > 54.0 µM),
FIGURE 1 | Effect of test compounds on P. verrucosa viability. (A) Antifungal effects of phendione, [Ag(phendione)2]
+, [Cu(phendione)3]
2+ and the simple salts,
AgClO4 and Cu(ClO4)2·6H2O. (B) MFC representative images of phendione and its Ag
+ and Cu2+ complexes on P. verrucosa growth. (A,B) Fungicidal effect was
considered when the MFC value was either equal to or up to 4 × MIC value for a compound (Pfaller et al., 2004), which was indicated by asterisk (*). ND, Not
determined.
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Cu2+ coordinated to phendione ([Cu(phendione)3]2+) was able
to inhibit 100% P. verrucosa proliferation at 5.0 µM. It is
believed that the phendione metal complexes have a higher
lipophilicity than the simple metal salts (Viganor et al., 2016).
This property is due to the total electron density reduction on
the free ligand upon complexation to the metal ion, and also
to the sharing of the positive charge of the metal cation with
N-donor atoms of the phendione ligand, which promotes an
electron delocalization all over the chelate ring (Raman et al.,
2014; Viganor et al., 2016). Aqueous DMSO, which was used as
the solvent for all of the test compounds, was inactive against
P. verrucosa conidial proliferation (data not shown). Altogether,
the present P. verrucosa growth inhibition results suggest that
the activity of the metal complexes as a whole is superior to
that of either the free metal ion or metal-free phendione ligand.
Ag+ (d10 outer electron configuration) complexes have zero
ligand field stabilization energy (LFSE) whilst octahedral Cu2+
(d9) has only a small amount of LFSE. As such, Ag+ and Cu2+
complexes are expected to be labile and the original chelating
phendione ligands are expected to be rapidly exchanged for
biological ligands present within the fungal cells and also in
the growth medium (amino acids, proteins, ammonia, chloride
etc.). It is thus likely that cell growth inhibition arises due to
the destructive interference of cellular processes by the metal ion
coupled with inactivation of other cell events by the phendione
ligand. It also appears that it is the phendione ligand component
of the administered metal complex that plays the dominant role
in the demise of the conidia.
Our previous results described that P. verrucosa was also
sensitive to 1,10-phenanthroline treatment, showing MIC equal
to 4.4 µM (0.8 µg/ml) (Granato et al., 2015). Thus, the
antifungal activity of 1,10-phenanthroline was superior to metal-
free phendione, but similar to its Ag+ and Cu2+ complexes.
However, neither 1,10-phenanthroline nor phendione presented
fungicidal effect against P. verrucosa (Granato et al., 2015).
Ultrastructural Alterations Induced by
Phendione and Its Metal Derivatives
The effect of phendione, [Ag(phendione)2]+ and
[Cu(phendione)3]2+ on P. verrucosa ultrastructure was
probed using SEM. In contrast to control cells, which had typical
spherical-to-oval morphology (Figures 2A,B), cells exposed
FIGURE 2 | Effect of test compounds on P. verrucosa ultrastructure. Representative SEM images showing untreated cells (control systems, A,B) and conidial
cells treated with phendione (C–F), [Cu(phendione)3]
2+ (G–J) and [Ag(phendione)2]
+ (L–O) at both MIC (C,D,G,H,L,M) and 2 × MIC (E,F,I,J,N,O). In contrast to
untreated conidial cells, treatment with the test compounds induced several ultrastructural alterations, including cell size increase (⋆), surface invaginations (:), cell
disruption (ï), surface detachment (ä), cellular debris ( ) and cell shrinkage ( ).
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to the test compounds exhibited several surface alterations,
such as detachment of cell wall components, invaginations,
cellular disruptions and shrinkages (Figures 2C–O), which
are indicative of cell death. [Cu(phendione)3]2+ was the
most aggressive in promoting changes on both conidial
architecture and morphology, for example, inducing cell size
increases when treated at the MIC concentration (Figure 2H)
and cellular debris following incubation with 2 × MIC
(Figures 2I,J).
Our previous study showed that 1,10-phenanthroline
(25 µM) also caused irreversible ultrastructure alterations on
P. verrucosa conidia, including cell wall detachment, intense
intracellular vacuolization and reduction in the cytoplasm
electron density (Granato et al., 2015). Similarly, phendione and
[Ag(phendione)2]+, both at 10 µg/ml, promoted changes
in the internal structure of C. albicans, as observed by
transmission electron microscopy (McCann et al., 2004). In
that work, phendione promoted an increase in size as well
as a reduction in the budding process of C. albicans yeast
cells. Furthermore, C. albicans exhibited a diffuse cell wall,
rupture of internal organelles and nucleus enlargement following
treatment with phendione. C. albicans yeast cells treated
with [Ag(phendione)2]+ had a distended cell wall, rupture
of membranous organelles and, in some cases, a fragmented
nucleus. Phendione and its Ag+ complex were both able to cause
a withdrawal of the cytoplasmic membrane from within the cell
wall in C. albicans (McCann et al., 2004).
Combination of [Cu(phendione)3]
2+ with
AMB Induces a Decrease in the Viability of
P. verrucosa
In this set of experiments, the most potent test compound,
[Cu(phendione)3]2+, was chosen to be combined with a selection
of classical antifungal agents in an attempt to check their ability
to control P. verrucosa growth. In this context, the combination
of [Cu(phendione)3]2+ with AMB, both of which were deployed
at (½ × MIC) concentrations, was able to significantly
inhibit the fungal proliferation by around 40% (Figure 3).
However, at the concentrations used, [Cu(phendione)3]2+ did
not positively compliment the activities of either KTC or ITC,
since P. verrucosa growth was not affected by these combinations
(Figure 3).
Eshwika and coworkers [22] showed that pre-growth of C.
albicans with sub-inhibitory concentrations (¼ × MIC90) of
[Ag(phendione)2]+ affected the subsequent susceptibility of
this yeast to miconazole and AMB, reducing the concentrations
of these clinical antifungal agents required to achieve MIC90.
Benefits of combination therapy are well-known and include
broad spectrum efficacy, greater potency compared to
monotherapy, improvements in both safety and tolerability
as well as a reduction in the emergence of resistance (Cuenca-
Estrella, 2004; Spitzer et al., 2016). Metal-based drugs can have
modes of action distinct from classical antifungal agents, allowing
their use in cases where there is resistance to conventional
therapies. Furthermore, different mode(s) of action can be used
by employing such metal-containing drugs in combination with
FIGURE 3 | Effect of a combination of [Cu(phendione)3]
2+ with
classical antifungal agents on P. verrucosa development. Conidia were
untreated (control) or treated with a sub-inhibitory concentration (½ × MIC) of
[Cu(phendione)3]
2+ and classical antifungal drugs (AMB, ITC and KTC), alone
or in combination. After 1 h, conidia were inoculated in a fresh solid
Czapek-Dox medium to measure the CFU. Conidia treated only with DMSO
(compound diluent) did not alter the cell growth. The values represent the
mean ± standard deviation of three independent experiments performed in
triplicate. Symbol (*) denotes the system that had a growth rate significantly
different from the control (P < 0.05, Student’s t test).
existing antifungals in order to target two (or more) sites in the
fungal cells. Thus, there is the potential of achieving the same
therapeutic effect by reducing the concentration of clinical drugs
used (Eshwika et al., 2004).
Phendione-Based Compounds Modulate
the Metallopeptidase Activity of
P. verrucosa
[Cu(phendione)3]2+ and [Ag(phendione)2]+ were capable of
inhibiting P. verrucosa extracellular metallopeptidase activity by
around 85 and 40%, respectively (Figure 4). However, the metal-
free ligand, phendione, did not affect this enzymatic activity
(Figure 4). The presence of metallopeptidase in P. verrucosa PBS-
glucose supernatant was confirmed by its inhibition by 10 mM of
1,10-phenanthroline (Figure 4).
Metal-chelating-type compounds may affect typical functions
of several eukaryotic proteins, such as various metallo-type
enzymes, including metallopeptidases (McCann et al., 2012b;
Santos et al., 2012; Granato et al., 2015). In fact, the inhibition
of metallopeptidases by 1,10-phenanthroline occurs mainly due
to its ability of promoting Zn2+ chelation, which is required
for catalytic activity and which leaves an inactive apoenzyme
(Santos et al., 2012). Our research group showed previously
that Zn2+ ions were able to stimulate the enzymatic activity of
P. verrucosa extracellular peptidase in a typical dose-dependent
manner, suggesting the presence of Zn2+-metallopeptidase in
this fungus (Granato et al., 2015). It is well-known that
metallopeptidase inhibition can prevent fungal cells to obtain
necessary peptides and amino acids for nutrition, leading to
reduction or complete inhibition of cell growth (Santos et al.,
2012).
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FIGURE 4 | Effects of phendione and its derivatives on P. verrucosa
metallopeptidase activity. PBS-glucose supernatant was incubated at
37◦C in 20mM sodium acetate buffer, pH 3.0, and HSA in the absence
(control) or in the presence of phendione and its metal complexes at
concentrations corresponding to 8 × MIC value. After 20 h, the supernatant
was subjected to the proteolytic activity assay, as detailed in Material and
Methods. The graphic shows densitometric quantification of the bands
observed in the SDS-PAGE (inset), which was performed using the software
ImageJ. The HSA fragment of the control system was taken as 100%.
Symbols (*) indicate the experimental systems considered statistically
significant from the control (P < 0.05, Student’s t-test). Inset: representative
images of SDS-PAGE, in which P. verrucosa supernatant was treated with
1,10-phenantroline at 10 mM (b) and 8 × MIC of all other compounds, such
as: phendione (c), [Ag(phendione)2]
+ (d) and [Cu(phendione)3]
2+ (e). Control
system contained only HSA and PBS-glucose supernatant (a). The number on
the left represents the HSA molecular mass, expressed in kDa. The arrows (→)
show fragmentation of the proteinaceous substrate after proteolysis.
Phendione and Its Metal Complexes Inhibit
Sterol Content of P. verrucosa Conidia
The treatment of conidial cells with phendione (¼ × MIC
and ½ × MIC) and also with [Ag(phendione)2]+ (½ × MIC)
promoted a reduction in ergosterol content by approximately
50% in relation to the control (untreated) cells (Figure 5). On the
contrary, [Cu(phendione)3]2+ did not affect the sterol content of
P. verrucosa (Figure 5).
Previous studies showed that sterol synthesis in C. albicans
was also disturbed by phendione and its metal complexes
(Eshwika et al., 2004). Interestingly, and in contrast to our
results, [Cu(phendione)3]2+ diminished the ergosterol content
in C. albicans yeast cells, while [Ag(phendione)2]+ enhanced the
amount of this lipid level (Eshwika et al., 2004). It is well-known
that sterol deficiency disturbs crucial cell membrane properties,
leading to an increased fluidity and permeability, which may
cause severe structural aberrations that contributes to cell death
(Kathiravan et al., 2012).
Phendione and Its Metal Complexes Affect
Fungal Morphological Transition
The present studies demonstrated that all the test compounds
were able to effectively block to a large extent the morphological
transition (conidia-into-mycelial transformation) when
FIGURE 5 | Effects of phendione and its metal complexes on
P. verrucosa sterol content. Conidia (1 × 107 cells/ml) were either untreated
(control) or treated for 48 h in the presence of sub-inhibitory concentrations (¼
× MIC and ½ × MIC) of each test compound. Afterwards, lipids were
extracted, and neutral lipids were applied onto HPTLC plates. Graphics
represent densitometric quantifications of results obtained by HPTLC using the
software ImageJ. The sterol content of the control system was taken as 100%.
Asterisk (*) denotes significant differences (P < 0.05, Student’s t test) between
treated systems and untreated cells (control).
compared to untreated fungal cells (Figure 6). It is important
to notice that hyphal formation was mostly inhibited by
phendione, followed by [Ag(phendione)2]+ and then by
[Cu(phendione)3]2+ (Figure 6). In fact, several conidia
(instead of hyphae form) were observed after the treatment
with phendione and [Ag(phendione)2]+, both used at a sub-
inhibitory concentration (¼ × MIC). It was also possible to
observe some conidial cells in the [Cu(phendione)3]2+ system
(¼×MIC); however, the highest effect of this compound was its
considerable ability to reduce hyphal branch growth (Figure 6).
Morphological transition is one of the strategies used by
several fungi to survive in environment and in vertebrate
hosts (Wang and Lin, 2012). In this context, several studies
have shown that cell differentiation is an essential step in the
establishment and success of fungal infection (Jacobsen et al.,
2012; Wang and Lin, 2012). We have previously demonstrated
that chelating compounds, such as 1,10-phenanthroline, were
able to inhibit the conidia-into-hyphae transformation in
P. verrucosa (Granato et al., 2015). Other studies also
reported the same capacity of 1,10-phenanthroline to affect
cell differentiation in C. albicans, Pseudallescheria boydii, and
Fonsecaea pedrosoi (Santos et al., 2012). The mechanisms
involved in the morphological transition of P. verrucosa have
not been established. It is well-known that several factors are
associated with fungal morphogenesis, including nutritional
elements, temperature and aerobic conditions (Wang and Lin,
2012). Mendoza et al. (1993) showed that CBM fungi, including
P. verrucosa produced large numbers of sclerotic bodies after
inoculation into a defined pH 2.5 medium containing the metal
ion Ca2+ at 0.1mM concentration. While higher concentrations
of Ca2+ (1mM) reversed this pattern and promotedmaintenance
of P. verrucosa hyphal growth. Addition of the Ca2+ chelator,
ethylene glycol tetraacetic acid (EGTA, 8mM) to the culture
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FIGURE 6 | Effects of phendione and its metal complexes on P. verrucosa filamentation. Conidia (1 × 106 cells/ml) were grown in RPMI medium in either the
absence (control) or the presence of sub-inhibitory concentration (¼ × MIC) of phendione, [Ag(phendione)2]
+ and [Cu(phendione)3]
2+. Conidia were observed before
(T = 0: zero time) and after 48 h of incubation (T = 48 h) by optical microscopy, when the fungal filamentous form (é) was produced. The inhibition of P. verrucosa
mycelial development by compounds was shown by conidia (á) observation and hyphal branch (ä) growth reduction.
medium induced P. verrucosa sclerotic bodies, demonstrating the
importance of metal ion Ca2+ in this fungal essential process
(Mendoza et al., 1993). In this context, these results revealed
that metal ion chelating agents can modulate morphological
transitions in CBM fungi.
CONCLUSIONS
Metal-free phendione and its Ag+ and Cu2+ complexes
are able to arrest the growth of P. verrucosa, especially
[Cu(phendione)3]2+, which also presented a fungicidal action.
In addition, these compounds blocked some vital fungal events,
such as filamentation, as well as reducing both sterol production
and the activity of metallo-type peptidase. Previous studies
reported that metal-based drugs showed tolerable toxicity in
vivo, confirming that they represent a novel group of antifungal
agents. Moreover, these compounds could be used alone or in
combination with classical antifungal agents, since P. verrucosa
had its growth inhibited after the combined treatment with
[Cu(phendione)3]2+ and AMB, as suggested in this study. In
conclusion, our data point out that metallo-drugs have potential
applications for the control and treatment of P. verrucosa
infections.
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